Company details

About

Alentis is exploiting the functional role of CLDN1 and its associated pathways in disease biology to develop breakthrough therapies for fibrotic diseases and associated cancers. These include liver and kidney disease as well as hepatobiliary cancer.

icon

Number of employees

1 - 10

icon

Main industry

Health Care

icon

Industry tags

icon

Founded in

2019

icon

Headquarters

Basel

icon

Country

Switzerland

Sign up to uncover company details

5 free credit every month

Employee contacts

Name

Job Title

Email

Phone

Reach Decision Makers
at Alentis Therapeutics

5 Free credits every month!

Sign up now to uncover all the contact details